GSK Pharma Income Statement
Quarterly
Yearly
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| EBITDA | 709 | 838 | 0 |
| EBIT | 458 | 781 | 0 |
| Earning Per Share | 21 | 22 | 36 |
| Expenses | 2,504 | 2,516 | 2,447 |
| Net Profit | 358 | 1,695 | 611 |
| Net Profit Margin | 11 | 12 | 19 |
| Operating Profit Margin | 25 | 26 | 28 |
| Profit Before Tax | 551 | 779 | 836 |
| Dividends Per Share | 30 | 90 | 0 |
| Operation Revenue | 3,309 | 3,354 | 3,352 |
Peer Comparison (in ₹.Cr.)
| Company | Year | EBIT | EBITDA | Net Profit | Net Worth | Profit Before Tax |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 8,560.84 | NA | 9,408.43 | |
| 2023 | 0 | 0 | 2,835.49 | NA | 4,038.35 | |
| 2023 | 0 | 0 | 372.90 | NA | 385.50 | |
| 2023 | 0 | 0 | 103.87 | NA | 140.39 | |
| 2022 | 1,257.60 | 2,182.90 | 978.50 | 7,628.10 | 1,190 |
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2005 | 2005 | 2005 | 2005 | 2023 | |
|---|---|---|---|---|---|
| Operating Activities | 349 | 349 | 349 | 349 | 484 |
| Investing Activities | 71 | 71 | 71 | 71 | 808 |
| Financing Activities | -444 | -444 | -444 | -444 | -1,543 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -24 | -24 | -24 | -24 | -251 |
Peer Comparison (in ₹.Cr.)
| Company | Year | Operating Activities | Investing Activities | Financing Activities | Net Cash Flow |
|---|---|---|---|---|---|
| 2023 | 4,959.33 | -7,943.68 | 2,376.07 | -608.28 | |
| 2022 | 3,325.90 | -1,871.88 | -1,599.79 | -145.77 | |
| 2023 | 723.95 | -447.59 | -261.96 | 14.40 | |
| 2020 | 140.90 | -44.50 | -38.55 | 57.85 | |
| 2017 | 640 | -498.50 | -177.50 | -36 |
Financials
All values are in Rs Cr